Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Albendazole suppresses cell proliferation and migration and induces apoptosis in human pancreatic cancer cells
Haifeng Chen et al.
ANTI-CANCER DRUGS (2020)
Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain
P. Ripani et al.
ONCOGENE (2020)
Niclosamide inhibits the cell proliferation and enhances the responsiveness of esophageal cancer cells to chemotherapeutic agents
Ming-Cheng Lee et al.
ONCOLOGY REPORTS (2020)
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells
Antonio Di Grazia et al.
CANCERS (2020)
Niclosamide inhibits ovarian carcinoma growth by interrupting cellular bioenergetics
Fugen Shangguan et al.
JOURNAL OF CANCER (2020)
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
Patrycja Nowak-Sliwinska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Anti-parasitic Drug Ivermectin Exhibits Potent Anticancer Activity Against Gemcitabine-resistant Cholangiocarcinoma In Vitro
Kitti Intuyod et al.
ANTICANCER RESEARCH (2019)
Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities
Eduardo Jose Barbosa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide
Federica Laudisi et al.
CANCER LETTERS (2019)
Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy
Jiangbo Wang et al.
BIOCHEMICAL JOURNAL (2019)
Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway
Ping Zhang et al.
CELL PROLIFERATION (2019)
Rafoxanide promotes apoptosis and autophagy of gastric cancer cells by suppressing PI3K /Akt/mTOR pathway
Jia-Zhou Liu et al.
EXPERIMENTAL CELL RESEARCH (2019)
Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma
Nancy S. Younis et al.
SCIENTIFIC REPORTS (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The novel role of pyrvinium in cancer therapy
Amir A. Momtazi-borojeni et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer
Yi Qu et al.
NATURE CHEMICAL BIOLOGY (2018)
Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress
Jiaqiao Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC
Wonyoung Choi et al.
CANCER RESEARCH (2018)
Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy
Dehong Chen et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2018)
Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer
Amer Alasadi et al.
CELL DEATH & DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The Effect of Flubendazole on Adhesion and Migration in SW480 and SW620 Colon Cancer Cells
Veronika Hanusova et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
Niclosamide Inhibits Cell Growth and Enhances Drug Sensitivity of Hepatocellular Carcinoma Cells via STAT3 Signaling Pathway
Chengzhi Wang et al.
JOURNAL OF CANCER (2018)
Lymph Node Metastases in Colon Cancer Are Polyclonal
Peter J. Ulintz et al.
CLINICAL CANCER RESEARCH (2018)
The high price of anticancer drugs: origins, implications, barriers, solutions
Vinay Prasad et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Drug repurposing in cancer
Linda Sleire et al.
PHARMACOLOGICAL RESEARCH (2017)
Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer
Sho Nambara et al.
ONCOTARGET (2017)
Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
J. Javier Hernandez et al.
FRONTIERS IN ONCOLOGY (2017)
Niclosamide: Beyond an antihelminthic drug
Wei Chen et al.
CELLULAR SIGNALLING (2017)
Inhibition of CUG-binding protein 1 and activation of caspases are critically involved in piperazine derivative BK10007S induced apoptosis in hepatocellular carcinoma cells
Ju-Ha Kim et al.
PLOS ONE (2017)
Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage
Min Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance
Nuno Vale et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pharmacologic resistance in colorectal cancer: a review
William A. Hammond et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
Closantel Suppresses Angiogenesis and Cancer Growth in Zebrafish Models
Xiao-Yu Zhu et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
Pyrvinium selectively induces apoptosis of lymphoma cells through impairing mitochondrial functions and JAK2/STAT5
Meifang Xiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cells
Shunyan Weng et al.
BMC GASTROENTEROLOGY (2016)
Key cost drivers of pharmaceutical clinical trials in the United States
Aylin Sertkaya et al.
CLINICAL TRIALS (2016)
Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro
Vera Kralova et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway
Malte B. Monin et al.
JOURNAL OF SURGICAL RESEARCH (2016)
Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
Tara Williamson et al.
ONCOTARGET (2016)
Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile
Major Gooyit et al.
SCIENTIFIC REPORTS (2016)
Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay
Yisu Li et al.
Scientific Reports (2016)
Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study
Supot Kamsa-Ard et al.
BMC CANCER (2015)
Potential Anti-cancer Drugs Commonly Used for Other Indications
Veronika Hanusova et al.
CURRENT CANCER DRUG TARGETS (2015)
Molecular Subtyping of Colorectal Cancer: Time to Explore Both Intertumoral and Intratumoral Heterogeneity to Evaluate Patient Outcome
Eric R. Fearon et al.
GASTROENTEROLOGY (2015)
Protein localization vector propagation: a method for improving the accuracy of drug repositioning
Yunku Yeu et al.
MOLECULAR BIOSYSTEMS (2015)
Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer
Wojciech Senkowski et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Drug repurposing in oncology-patient and health systems opportunities
Francesco Bertolini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model
Laine Celestino Pinto et al.
TOXICOLOGY IN VITRO (2015)
Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration
Wei Xiang et al.
ONCOTARGET (2015)
Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
Rebecca Lamb et al.
ONCOTARGET (2015)
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth
V. De Simone et al.
ONCOGENE (2015)
Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer
Peter Nygren et al.
ACTA ONCOLOGICA (2014)
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Jean-Francois Rossignol
ANTIVIRAL RESEARCH (2014)
The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer
Alice Melotti et al.
EMBO MOLECULAR MEDICINE (2014)
The impact of pyrvinium pamoate on colon cancer cell viability
Armin Wiegering et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Novel Piperazine-based Compounds Inhibit Microtubule Dynamics and Sensitize Colon Cancer Cells to Tumor Necrosis Factor-induced Apoptosis
Avijeet Chopra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
Bin Li et al.
PLOS ONE (2014)
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Labianca et al.
ANNALS OF ONCOLOGY (2013)
Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines
Vera Kralova et al.
ANTI-CANCER DRUGS (2013)
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
Peter Nygren et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Diagnosing the decline in pharmaceutical R&D efficiency
Jack W. Scannell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Praziquantel Synergistically Enhances Paclitaxel Efficacy to Inhibit Cancer Cell Growth
Zhen Hua Wu et al.
PLOS ONE (2012)
Levamisole receptors: a second awakening
Richard J. Martin et al.
TRENDS IN PARASITOLOGY (2012)
Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations
Takuya Osada et al.
CANCER RESEARCH (2011)
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Curtis A. Thorne et al.
NATURE CHEMICAL BIOLOGY (2010)
Rapidly rising clinical trial costs worry researchers
Roger Collier
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells
Joachim Mueller et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy
De-Hua Yu et al.
PLOS ONE (2008)
Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells
L. -Y. Chen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Colorectal cancer and genetic alterations in the Wnt pathway
S. Segditsas et al.
ONCOGENE (2006)
Nitazoxanide for the treatment of Clostridium difficile colitis
Daniel M. Musher et al.
CLINICAL INFECTIOUS DISEASES (2006)
Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis
MH Pourgholami et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H- pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation
H Esumi et al.
CANCER SCIENCE (2004)
Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru
JJ Ortiz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole
MH Pourgholami et al.
CANCER LETTERS (2001)
Pilot study of albendazole in patients with advanced malignancy - Effect on serum tumor markers/high incidence of neutropenia
DL Morris et al.
ONCOLOGY (2001)
Share Paper
